LDL-C and outcomes: Implementing 21st century cardiovascular trials

1 September 2019 (13:30 - 13:45)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Louise Bowman

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Welcome and introductions.

Doctor B. Berkowitz (New York, US)

Presentation thumbnail

Atherosclerotic cardiovascular disease management has made significant progress but may have stalled recently.

Doctor C. Gibson (Boston, US)

Presentation thumbnail

The ORION Program - Rationale and emerging evidence

Doctor D. Kallend (Zurich, CH)

Presentation thumbnail

Another PCSK-9 therapy?

Professor R. Wright (Rochester, US)

Presentation thumbnail

Approaches to critically assess the evidence. A checklist for ORION-11

Doctor C. Gibson (Boston, US)

Access the full session

Session thumbnail

The ORION Program - What to look for in ORION-11

The Event

ESC Congress 2019

1 September 2019 13:30 CET

You may be interested in

Congress Presentation

Prognostic impact of achieving LDL cholesterol guidelines-recommended target in secondary prevention: a real-world study

27 August 2021

Congress Presentation

Redrawing the map: why we must cross boundaries in lipid management

29 August 2025

Congress Presentation

Association of LDL cholesterol levels and all cause mortality in a real world analysis using data from an international network

28 August 2023

Congress Presentation

Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE

4 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources